Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
Conclusions
COVID-19 vaccine booster strengthens humoral and Th1-cell responses and increases TEM cells in PwMS.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Aiello, A., Coppola, A., Ruggieri, S., Farroni, C., Altera, A. M. G., Salmi, A., Vanini, V., Cuzzi, G., Petrone, L., Meschi, S., Lapa, D., Bettini, A., Haggiag, S., Prosperini, L., Galgani, S., Quartuccio, M. E., Bevilacqua, N., Garbuglia, A. R., Agrati, Tags: Open access, COVID-19 Multiple sclerosis Source Type: research
More News: Brain | Covid Vaccine | COVID-19 | Gilenya | Multiple Sclerosis | Neurology | Neurosurgery | Psychiatry | Vaccines